- Vertex Pharmaceuticals (VRTX -0.5%) reports Q2 results after the close. Consensus view is a loss per share of ($0.58) (+4.9%) on revenues of $149.7M (+8.5%).
Vertex Pharma reports after the close
Recommended For You
More Trending News
About VRTX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| VRTX | - | - |
| Vertex Pharmaceuticals Incorporated | ||